Cite
HARVARD Citation
Pandha, H. et al. (n.d.). Phase I/II storm study: Intravenous delivery of a novel oncolytic immunotherapy agent, Coxsackievirus A21, in advanced cancer patients. Journal for immunotherapy of cancer. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Pandha, H. et al. (n.d.). Phase I/II storm study: Intravenous delivery of a novel oncolytic immunotherapy agent, Coxsackievirus A21, in advanced cancer patients. Journal for immunotherapy of cancer. p. . [Online].